Clinical trial
KALETRA in Combination With New Substances (PROTEKT)
NCT01076179 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- KALETRA in Combination With New Substances (PROTEKT)
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- January 31, 2016
- Enrollment
- 502 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus